These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31229666)
81. A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role. Chan WC; Linn YC Cytotechnology; 2016 Aug; 68(4):735-48. PubMed ID: 25481728 [TBL] [Abstract][Full Text] [Related]
82. Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation. Mareschi K; Adamini A; Castiglia S; Rustichelli D; Castello L; Mandese A; Leone M; Pinnetta G; Mesiano G; Ferrero I; Fagioli F Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32408620 [TBL] [Abstract][Full Text] [Related]
83. Changes in the TCR repertoire of T-cell subsets during culture of cytokine-induced killer cells. Liang G; Feng G; Chen H; Li L; Hu J; Zhou C; Li J; Shen H; Wu F; Tao C; Liu Y; Zhang W; Shao H FEBS Lett; 2022 Oct; 596(20):2696-2705. PubMed ID: 36129621 [TBL] [Abstract][Full Text] [Related]
84. A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses. Cimen Bozkus C; Blazquez AB; Enokida T; Bhardwaj N STAR Protoc; 2021 Sep; 2(3):100758. PubMed ID: 34458873 [TBL] [Abstract][Full Text] [Related]
85. Improving cytokine-induced killer cell expansion using a gas-permeable culture method for clinical-scale production. Tawinwung S; Tudsamran S; Thaiwong R; Asawapanumas T; Wudhikarn K; Chanswangphuwana C; Hirankarn N; Bunworasate U; Suppipat K Asian Pac J Allergy Immunol; 2023 Jan; ():. PubMed ID: 36592164 [TBL] [Abstract][Full Text] [Related]
89. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703 [TBL] [Abstract][Full Text] [Related]
90. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens. Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893 [TBL] [Abstract][Full Text] [Related]
91. Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. Bao L; Dunham K; Stamer M; Mulieri KM; Lucas KG Biol Blood Marrow Transplant; 2008 Oct; 14(10):1156-1162. PubMed ID: 18804046 [TBL] [Abstract][Full Text] [Related]
92. A novel simplified method of generating cytomegalovirus-specific cytokine-induced killer cells of high specificity and superior potency with GMP compliance. Luah YH; Sundar Raj K; Koh MBC; Linn YC Clin Immunol; 2019 Aug; 205():83-92. PubMed ID: 31229666 [TBL] [Abstract][Full Text] [Related]